Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanism

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013. PMID: 21376230.
   PubMed Web of Science ®Google Scholar
• Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306. doi:10.1186/1471-2407-12-306. PMID:22824040.
   PubMed Web of Science ®Google Scholar
• Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med. 2010;362(10):875–85. doi:10.1056/NEJMoa0905680. PMID:20220182.
   PubMed Web of Science ®Google Scholar
• Hu W, Qian Y, Yu F, Liu W, Wu Y, Fang X, Hao W. Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma. Oncol Lett. 2015;10(3):1390–96. doi:10.3892/ol.2015.3400. PMID:26622679
   PubMed Web of Science ®Google Scholar
• Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007;117(5):1155–66. doi:10.1172/JCI31422. PMID:17476345.
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–5. doi:10.1038/nature10138. PMID:21654748.
   PubMed Web of Science ®Google Scholar
• Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 2014;25(6):846–59. doi:10.1016/j.ccr.2014.05.016. PMID;24898549
   PubMed Web of Science ®Google Scholar
• Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193(6):727–40. doi:10.1084/jem.193.6.727. PMID:11257139.
   PubMed Web of Science ®Google Scholar
• Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91(4):411–29. doi:10.1007/s00109-013-1021-5. PMID:23515621.
   PubMed Web of Science ®Google Scholar
• Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol. 2008;18(5):349–55. doi:10.1016/j.semcancer.2008.03.004. PMID:18467122
   PubMed Web of Science ®Google Scholar
• Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614. doi:10.3389/fimmu.2014.00614. PMID:25506346
   PubMed Web of Science ®Google Scholar
• Sinha P, Clements VK, Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res. 2005;65(24):11743–51. doi:10.1158/0008-5472.CAN-05-0045. PMID:16357187.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009;16(2):91–102. doi:10.1016/j.ccr.2009.06.018. PMID:19647220.
   PubMed Web of Science ®Google Scholar
• Davies LC, Taylor PR. Tissue-resident macrophages: then and now. Immunology. 2015;144(4):541–48. doi:10.1111/imm.12451. PMID:25684236.
   PubMed Web of Science ®Google Scholar
• Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518(7540):547–51. doi:10.1038/nature13989. PMID:25470051.
   PubMed Web of Science ®Google Scholar
• Hoeffel G, Chen J, Lavin Y, Low D, Almeida FF, See P, Beaudin AE, Lum J, Low I, Forsberg EC, et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity. 2015;42(4):665–78. doi:10.1016/j.immuni.2015.03.011. PMID:25902481.
   PubMed Web of Science ®Google Scholar
• Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014;159(6):1312–26. doi:10.1016/j.cell.2014.11.018. PMID:25480296.
   PubMed Web of Science ®Google Scholar
• van de Laar L, Saelens W, De Prijck S, Martens L, Scott CL, Van Isterdael G, Hoffmann E, Beyaert R, Saeys Y, Lambrecht BN, et al. Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages. Immunity. 2016;44(4):755–68. doi:10.1016/j.immuni.2016.02.017. PMID:26992565.
   PubMed Web of Science ®Google Scholar
• Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013;218(11):1402–10. doi:10.1016/j.imbio.2013.06.003. PMID:23891329.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Chintala NK, Vadrevu SK, Patel J, Karbowniczek M, Markiewski MM. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194(11):5529–38. doi:10.4049/jimmunol.1403215. PMID:25911761.
   PubMed Web of Science ®Google Scholar
• Wang DH, Lee HS, Yoon D, Berry G, Wheeler TM, Sugarbaker DJ, Kheradmand F, Engleman EG, Burt BM. Progression of EGFR mutant lung adenocarcinoma is driven by alveolar macrophages. Clin Cancer Res 2016;23(3):778–88. doi:10.1158/1078-0432.CCR-15-2597. PMID:27496865.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–22. doi:10.1016/j.ccr.2012.02.022. PMID:22439926.
   PubMed Web of Science ®Google Scholar
• Tasian SK, Doral MY, Borowitz MJ, Wood BL, Chen IM, Harvey RC, Gastier-Foster JM, Willman CL, Hunger SP, Mullighan CG, et al. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012;120(4):833–42. doi:10.1182/blood-2011-12-389932. PMID:22685175.
   PubMed Web of Science ®Google Scholar
• De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med. 2011;208(3):469–78. doi:10.1084/jem.20101876. PMID:21339327.
   PubMed Web of Science ®Google Scholar
• Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011;208(3):479–90. doi:10.1084/jem.20102131. PMID:21339324.
   PubMed Web of Science ®Google Scholar
• Demehri S, Cunningham TJ, Manivasagam S, Ngo KH, Moradi Tuchayi S, Reddy R, Meyers MA, DeNardo DG, Yokoyama WM. Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis. J Clin Invest. 2016;126(4):1458–70. doi:10.1172/JCI83724. PMID:26927668.
   PubMed Web of Science ®Google Scholar
• Burgess DJ. Tumour immunology: Context is key for TSLP. Nat Rev Cancer. 2012;12(12):796–97. doi:10.1038/nrc3405. PMID:23175117.
   PubMed Web of Science ®Google Scholar
• Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012;91(6):877–86. doi:10.1189/jlb.1211622. PMID:22442496.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–67. doi:10.1038/nature01322. PMID:12490959.
   PubMed Web of Science ®Google Scholar
• Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A. Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J Immunol. 2011;186(10):5656–62. doi:10.4049/jimmunol.1100463. PMID:21490155.
   PubMed Web of Science ®Google Scholar
• Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2001; Chapter 20(Unit 20.2). doi:10.1002/0471142735.im2002s39. PMID:18432775
   PubMedGoogle Scholar
• Waight JD, Netherby C, Hensen ML, Miller A, Hu Q, Liu S, Bogner PN, Farren MR, Lee KP, Liu K, et al. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J Clin Invest. 2013;123(10):4464–78. doi:10.1172/JCI68189. PMID:24091328.
   PubMed Web of Science ®Google Scholar
• Johnstone CN, Smith YE, Cao Y, Burrows AD, Cross RS, Ling X, Redvers RP, Doherty JP, Eckhardt BL, Natoli AL, et al. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis Model Mech. 2015;8(3):237–51. doi:10.1242/dmm.017830. PMID:25633981.
   PubMed Web of Science ®Google Scholar
• Twentyman PR, Wright KA, Fox NE. Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil. Br J Cancer 1990;61(2):279–84. doi:10.1038/bjc.1990.52. PMID:1968761.
   PubMed Web of Science ®Google Scholar
• Caldwell SA, Ryan MH, McDuffie E, Abrams SI. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases. J Immunol. 2003;171(5):2402–12. doi:10.4049/jimmunol.171.5.2402. PMID:12928387.
   PubMed Web of Science ®Google Scholar
• Segawa R, Yamashita S, Mizuno N, Shiraki M, Hatayama T, Satou N, Hiratsuka M, Hide M, Hirasawa N. Identification of a cell line producing high levels of TSLP: advantages for screening of anti-allergic drugs. J Immunol Methods. 2014;402(1–2):9–14. doi:10.1016/j.jim.2013.10.012. PMID:24252242.
   PubMed Web of Science ®Google Scholar
• Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer. 2006;95(3):272–81. doi:10.1038/sj.bjc.6603240. PMID:16832418.
   PubMed Web of Science ®Google Scholar
• Li Z, Xu X, Feng X, Murphy PM. The Macrophage-depleting Agent Clodronate Promotes Durable Hematopoietic Chimerism and Donor-specific Skin Allograft Tolerance in Mice. Sci Rep. 2016;6:22143. doi:10.1038/srep22143. PMID:26917238.
   PubMed Web of Science ®Google Scholar
• Park MK, Ngo V, Kwon YM, Lee YT, Yoo S, Cho YH, Hong SM, Hwang HS, Ko EJ, Jung YJ, et al. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS One. 2013;8(10):e75368. doi:10.1371/journal.pone.0075368. PMID:24124485.
   PubMed Web of Science ®Google Scholar
• Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med. 2006;203(2):269–73. doi:10.1084/jem.20051745. PMID:16432252.
   PubMed Web of Science ®Google Scholar
• Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol. 2005;6(10):1047–53. doi:10.1038/ni1247. PMID:16142237.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253–68. doi:10.1038/nri3175. PMID:22437938.
   PubMed Web of Science ®Google Scholar
• Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol. 2006;176(1):284–90. doi:10.4049/jimmunol.176.1.284. PMID:16365420.
   PubMed Web of Science ®Google Scholar
• Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi:10.1016/j.cell.2010.03.014. PMID:20371344.
   PubMed Web of Science ®Google Scholar
• Williams CB, Yeh ES, Soloff AC. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer. 2016;2:15025. doi:10.1038/npjbcancer.2015.25. PMID: 26998515.
   PubMed Web of Science ®Google Scholar
• Ohgawara T, Kubota S, Kawaki H, Kurio N, Abd El Kader T, Hoshijima M, Janune D, Shimo T, Perbal B, Sasaki A, et al. Association of the metastatic phenotype with CCN family members among breast and oral cancer cells. J Cell Commun Signal. 2011;5(4):291–99. doi:10.1007/s12079-011-0133-3. PMID:21499980.
   PubMed Web of Science ®Google Scholar
• Tripurani SK, Cook RW, Eldin KW, Pangas SA. BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors. Oncogene. 2013;32(33):3877–85. doi:10.1038/onc.2012.392. PMID:22964636.
   PubMed Web of Science ®Google Scholar
• Bonapace L, Coissieux MM, Wyckoff J, Mertz KD, Varga Z, Junt T, Bentires-Alj M. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014;515(7525):130–33. doi:10.1038/nature13862. PMID:25337873.
   PubMed Web of Science ®Google Scholar
• Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014;5(9):2736–49. doi:10.18632/oncotarget.1932. PMID:24811362.
   PubMed Web of Science ®Google Scholar
• Yu PF, Huang Y, Han YY, Lin LY, Sun WH, Rabson AB, Wang Y, Shi YF. TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene. 2017;36(4):482–90. doi:10.1038/onc.2016.217. PMID:27669436.
   PubMed Web of Science ®Google Scholar
• Waight JD, Hu Q, Miller A, Liu S, Abrams SI. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One. 2011;6(11):e27690. doi:10.1371/journal.pone.0027690. PMID:22110722.
   PubMed Web of Science ®Google Scholar
• Han H, Headley MB, Xu W, Comeau MR, Zhou B, Ziegler SF. Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. J Immunol. 2013;190(3):904–12. doi:10.4049/jimmunol.1201808. PMID:23275605.
   PubMed Web of Science ®Google Scholar
• Barooei R, Mahmoudian RA, Abbaszadegan MR, Mansouri A, Gholamin M. Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer. Med Oncol. 2015;32(8):217. doi:10.1007/s12032-015-0653-4. PMID:26175262.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370(22):2102–10. doi:10.1056/NEJMoa1402895. PMID:24846652.
   PubMed Web of Science ®Google Scholar
• Stewart TJ, Abrams SI. Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth. J Immunol. 2007;179(5):2851–59. doi:10.4049/jimmunol.179.5.2851. PMID:17709499.
   PubMed Web of Science ®Google Scholar
• Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64(6):2205–11. doi:10.1158/0008-5472.CAN-03-2646. PMID:15026364.
   PubMed Web of Science ®Google Scholar